MZH — Nanofilm Technologies International Balance Sheet
0.000.00%
- SG$423.62m
- SG$473.78m
- SG$204.27m
- 79
- 35
- 73
- 71
Annual balance sheet for Nanofilm Technologies International, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 227 | 183 | 157 | 156 | 111 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 113 | 128 | 112 | 90.7 | 125 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 357 | 329 | 288 | 269 | 257 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 175 | 290 | 289 | 300 | 305 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 549 | 645 | 618 | 621 | 635 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 87.7 | 74.1 | 57.7 | 45.8 | 56.4 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 118 | 215 | 199 | 242 | 247 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 431 | 430 | 419 | 380 | 388 |
| Total Liabilities & Shareholders' Equity | 549 | 645 | 618 | 621 | 635 |
| Total Common Shares Outstanding |